Biomarin Pharmaceutical Inc (BMRN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Biomarin Pharmaceutical Inc-Aktie (BMRN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.68% 874.57	776.13	825.41	745.14	747.31
Cost Of Revenue	96.82% 275.71	140.09	150.09	151.56	136.14
Gross Profit	5.85% 598.86	636.05	675.32	593.59	611.17
Operating Expenses	5.75% 643.47	682.74	398.43	369.69	449.77
Benefits Costs and Expenses	12.37% 901.72	802.46	527.54	507.06	577.67
Costs And Expenses	11.71% 919.17	822.83	548.52	521.25	585.91
Operating Income/Loss	4.46% -44.61	-46.69	276.89	223.89	161.41
Income/Loss From Continuing Operations Before Tax	3.15% -27.15	-26.32	297.87	238.09	169.64
Income Tax Expense/Benefit, Deferred	104.49% 0.613	-13.65	33.34	28.43	42.39
Income Tax Expense/Benefit	339.37% 19.42	4.42	57.34	52.40	44.70
Income/Loss From Continuing Operations After Tax	51.49% -46.57	-30.74	240.53	185.69	124.94
Net Income/Loss	51.49% -46.57	-30.74	240.53	185.69	124.94
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.92% 0.148	192.03	191.91	190.97	0.221
Diluted Average Shares	99.74% 0.501	192.03	197.09	196.47	0.025
Basic Earnings Per Share	50.00% -0.24	-0.16	1.25	0.97	0.66
Diluted Earnings Per Share	50.00% -0.24	-0.16	1.23	0.95	0.65
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%